1. Distinguish hepatitis strains in symptomatic patients in order to provide an accurate diagnosis and prescribe appropriate therapies.
2. Assess the prevalence of viral hepatitis in your patient population and identify patients who should receive the hepatitis A and B vaccines.
3. Evaluate training needs on laboratory testing methods for hepatitis and appropriate interpretation of results.
4. Counsel patients on behavioral modifications to reduce the risk of exposure to hepatitis strains.
5. Compare treatment options for patients with viral hepatitis.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
David T. Walsworth, MD, FAAFP, Chair, Associate Chair for Clinical Affairs and Associate Professor, Department of Family Medicine, College of Human Medicine, Michigan State University
B. Wayne Blount, MD, MPH, FAAFP, Medical Director, JenCare; Professor, Department of Family Medicine, Emory University School of Medicine, Atlanta
- 0.75 AAFP prescribed